Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pathogenesis of Basedow's disease].

H Wuttke

    Fortschritte Der Medizin
    |December 7, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Thyroid antibodies and thyroid-stimulating factors (LATS) are linked in Graves' disease patients. These immunoglobulins indicate immune involvement, but their persistence challenges the current autoimmune pathogenesis theory.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impact of the CYP2D6 genotype on the clinical effects of metoprolol: a prospective longitudinal study.

    Clinical pharmacology and therapeutics·2008
    Same author

    Valdecoxib does not interfere with the CYP2D6 substrate metoprolol.

    International journal of clinical pharmacology and therapeutics·2006
    Same author

    [Genetic polymorphisms in drug metabolizing enzymes--impact on treatment with beta-blockers].

    Deutsche medizinische Wochenschrift (1946)·2004
    Same author

    Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure.

    Journal of the American College of Cardiology·2001
    Same author

    [Stimulation of endogenous TSH secretion and endocrine orbitopathy].

    Medizinische Klinik·1980
    Same author

    [Function of the thyroid gland following percutaneous radiation therapy in the region of the neck (author's transl)].

    Strahlentherapie·1980
    Same journal

    [More information--less pain. Procedure in pain following amputation of limbs. Brachial plexus injury and nerve root avulsion. Interview by Susanne Kammerer].

    Fortschritte der Medizin·1999
    Same journal

    [Galenic alternatives to unstable tocopherol acetate. "Smeared" or cheated?--Vitamin E in facial ointments].

    Fortschritte der Medizin·1999
    Same journal

    [Gene diagnosis in the hand of the physician].

    Fortschritte der Medizin·1999
    Same journal

    [Is non-toxic cancer therapy through biotechnology a possibility?].

    Fortschritte der Medizin·1999
    Same journal

    [Smoking withdrawal in practice and clinic].

    Fortschritte der Medizin·1999
    Same journal

    [The future of pancreas diagnosis. An exclusive training service of the Gastro-Ligue for dermatologists].

    Fortschritte der Medizin·1999
    See all related articles

    Area of Science:

    • Endocrinology
    • Immunology

    Background:

    • Graves' disease is an autoimmune disorder affecting the thyroid.
    • Thyroid-stimulating factors, including LATS and LATS-Protector, are implicated in its pathogenesis.

    Purpose of the Study:

    • To investigate the relationship between thyroid antibodies and thyroid-stimulating factors in Graves' disease patients undergoing treatment.
    • To evaluate the persistence of these factors after treatment cessation and their implications for disease understanding.

    Main Methods:

    • Controlled study of 53 Graves' disease patients during antithyroid drug treatment.
    • Measurement of thyroid antibodies and thyroid-stimulating factors (LATS, LATS-Protector).
    • Assessment of thyroid function suppressibility and factor levels post-treatment.

    Related Experiment Videos

    Main Results:

    • Antibody-positive patients required higher drug dosages and longer treatment durations.
    • Thyroid antibodies were only found in patients with detectable thyroid-stimulating immunoglobulins.
    • Thyroid-stimulating factors persisted in some patients even when thyroid function normalized post-treatment.

    Conclusions:

    • Results highlight the significant role of immunologic processes in Graves' disease.
    • The persistence of thyroid-stimulating factors despite normalized thyroid function challenges the established autoimmune pathogenesis model.
    • Further research is needed to explore factors influencing LATS/LATS-Protector effectiveness or receptor interactions.